Logo image of MCOM

MICROMOBILITY.COM INC (MCOM) Stock Fundamental Analysis

NASDAQ:MCOM - Nasdaq - US42309B6002 - Common Stock - Currency: USD

0.22  -0.22 (-50.55%)

After market: 0.205 -0.02 (-6.82%)

Fundamental Rating

1

Taking everything into account, MCOM scores 1 out of 10 in our fundamental rating. MCOM was compared to 41 industry peers in the Ground Transportation industry. MCOM has a bad profitability rating. Also its financial health evaluation is rather negative. MCOM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MCOM had negative earnings in the past year.
In the past year MCOM has reported a negative cash flow from operations.
MCOM Yearly Net Income VS EBIT VS OCF VS FCFMCOM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -20M -40M -60M -80M

1.2 Ratios

The Return On Assets of MCOM (-865.54%) is worse than 97.37% of its industry peers.
Industry RankSector Rank
ROA -865.54%
ROE N/A
ROIC N/A
ROA(3y)-241.5%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MCOM Yearly ROA, ROE, ROICMCOM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 200 -200 400 600 800

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MCOM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MCOM Yearly Profit, Operating, Gross MarginsMCOM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 -200 -400 -600

More info and screens

0

2. Health

2.1 Basic Checks

MCOM does not have a ROIC to compare to the WACC, probably because it is not profitable.
MCOM has more shares outstanding than it did 1 year ago.
The debt/assets ratio for MCOM is higher compared to a year ago.
MCOM Yearly Shares OutstandingMCOM Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 5M 10M 15M
MCOM Yearly Total Debt VS Total AssetsMCOM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 10M 20M 30M 40M 50M

2.2 Solvency

MCOM has an Altman-Z score of -61.01. This is a bad value and indicates that MCOM is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -61.01, MCOM is not doing good in the industry: 97.37% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -61.01
ROIC/WACCN/A
WACC2.72%
MCOM Yearly LT Debt VS Equity VS FCFMCOM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 -20M -40M

2.3 Liquidity

A Current Ratio of 0.07 indicates that MCOM may have some problems paying its short term obligations.
MCOM has a worse Current ratio (0.07) than 92.11% of its industry peers.
A Quick Ratio of 0.07 indicates that MCOM may have some problems paying its short term obligations.
MCOM has a worse Quick ratio (0.07) than 92.11% of its industry peers.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
MCOM Yearly Current Assets VS Current LiabilitesMCOM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 89.27% over the past year.
The Revenue for MCOM has decreased by -14.99% in the past year. This is quite bad
MCOM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 143.22% yearly.
EPS 1Y (TTM)89.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.73%
Revenue 1Y (TTM)-14.99%
Revenue growth 3Y143.23%
Revenue growth 5YN/A
Sales Q2Q%-57.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MCOM Yearly Revenue VS EstimatesMCOM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MCOM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MCOM Price Earnings VS Forward Price EarningsMCOM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MCOM Per share dataMCOM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MCOM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MICROMOBILITY.COM INC

NASDAQ:MCOM (12/19/2023, 10:10:50 PM)

After market: 0.205 -0.02 (-6.82%)

0.22

-0.22 (-50.55%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)11-15 2023-11-15/amc
Earnings (Next)03-26 2024-03-26/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners0.73%
Ins Owner Change0%
Market Cap1.80M
Analysts85.71
Price TargetN/A
Short Float %0.9%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-11.48
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-4.8
FCFYN/A
OCF(TTM)-4.71
OCFYN/A
SpS1.61
BVpS-6.4
TBVpS-6.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -865.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-241.5%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.4
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 11.73%
Cap/Sales 5.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z -61.01
F-Score4
WACC2.72%
ROIC/WACCN/A
Cap/Depr(3y)129.55%
Cap/Depr(5y)N/A
Cap/Sales(3y)65.86%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.73%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.99%
Revenue growth 3Y143.23%
Revenue growth 5YN/A
Sales Q2Q%-57.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-11.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.16%
OCF growth 3YN/A
OCF growth 5YN/A